{"id":1257,"date":"2020-07-20T10:56:27","date_gmt":"2020-07-20T14:56:27","guid":{"rendered":"http:\/\/miunidad.eu\/purib2\/?p=1257"},"modified":"2022-06-06T14:44:04","modified_gmt":"2022-06-06T12:44:04","slug":"tratamiento-con-add-para-hepatitis-c-en-poblacion-reclusa","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/tratamiento-con-add-para-hepatitis-c-en-poblacion-reclusa\/","title":{"rendered":"Tratamiento con ADD para Hepatitis C en poblaci\u00f3n reclusa"},"content":{"rendered":"<p>El tratamiento con antivirales de acci\u00f3n directa (ADD) para poblaci\u00f3n reclusa con hepatitis C cr\u00f3nica (HCc) podr\u00eda ser una estrategia altamente coste-efectiva considerando el umbral de disponibilidad a pagar utilizado en Espa\u00f1a (22.000-30.000 \u20ac\/AVAC), seg\u00fan se desprende de la publicaci\u00f3n en la que ha trabajado PORIB; Cost-effectiveness analysis of chronic hepatitis C treatment in the prison population in Spain.<\/p>\n<p>El art\u00edculo, publicado en la Revista Espa\u00f1ola de Sanidad Penitenciaria, presenta datos positivos del impacto cl\u00ednico y econ\u00f3mico del tratamiento con (AAD) sobre las mortalidad y complicaciones hep\u00e1ticas, aumentando la supervivencia y reduciendo los costes asociados al manejo de la enfermedad.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El tratamiento con antivirales de acci\u00f3n directa (ADD) para poblaci\u00f3n reclusa con hepatitis C cr\u00f3nica (HCc) podr\u00eda ser una estrategia altamente coste-efectiva considerando el umbral de disponibilidad a pagar utilizado en Espa\u00f1a (22.000-30.000 \u20ac\/AVAC), seg\u00fan se desprende de la publicaci\u00f3n en la que ha trabajado PORIB; Cost-effectiveness analysis of chronic hepatitis C treatment in the&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/porib.com\/en\/tratamiento-con-add-para-hepatitis-c-en-poblacion-reclusa\/\" class=\"excerpt-read-more\">Read More<i class=\"fa fa-caret-right icon-caret-right\"><\/i><\/a><\/p>\n","protected":false},"author":1,"featured_media":18180,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":["post-1257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ultimas-noticias"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/1257"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=1257"}],"version-history":[{"count":4,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/1257\/revisions"}],"predecessor-version":[{"id":18181,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/1257\/revisions\/18181"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media\/18180"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=1257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=1257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=1257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}